Aurobindo Pharma's Eugia Pharma approved to manufacture Dasatinib Tablets, a bioequivalent to Bristol-Myers Squibb's Sprycel, ...

The Nifty Midcap index closed 1.18 percent higher at 55,041, while Nifty Smallcap index ended the session with marginal gains ...

Tractor delivery momentum is expected to continue in Q1FY26 on expectation of very good Rabi crop harvest and improved cash ...

Eugia Pharma, a subsidiary of Aurobindo Pharma, has secured final USFDA approval for manufacturing and marketing Dasatinib ...

Examine the best colleges in India offering Pharma courses as per NIRF Rankings, along with courses offered, seat intake, ...

After a consistent five-day rally, the market may consolidate, though the overall trend remains positive. Below are some ...